Výsledky vyhledávání - "Richard-Le Goff O"

Akademický článek

High-affinity autoreactive plasma cells disseminate through multiple organs in patients with immune thrombocytopenic purpura.

Autor: Canales-Herrerias P; Institut Pasteur, Université Paris Cité, INSERM UMR1222, Unit of Antibodies in Therapy and Pathology, Paris, France.; Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France., Crickx E; Institut Necker-Enfants Malades, INSERM U1151/CNRS UMS8253, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.; Service de Médecine Interne, Centre national de référence des cytopénies auto-immunes de l'adulte, Hôpital Henri Mondor, Assistance Publique Hôpitaux de Paris (AP-HP), Université Paris Est Créteil, Créteil, France., Broketa M; Institut Pasteur, Université Paris Cité, INSERM UMR1222, Unit of Antibodies in Therapy and Pathology, Paris, France.; Diaccurate SA, Paris, France.; Sorbonne University, ED394, Paris, France., Sokal A; Institut Necker-Enfants Malades, INSERM U1151/CNRS UMS8253, Université Paris Descartes, Sorbonne Paris Cité, Paris, France., Chenon G; Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France., Azzaoui I; Service de Médecine Interne, Centre national de référence des cytopénies auto-immunes de l'adulte, Hôpital Henri Mondor, Assistance Publique Hôpitaux de Paris (AP-HP), Université Paris Est Créteil, Créteil, France.; INSERM U955, Université Paris Est Créteil (UPEC), Créteil, France., Vandenberghe A; Service de Médecine Interne, Centre national de référence des cytopénies auto-immunes de l'adulte, Hôpital Henri Mondor, Assistance Publique Hôpitaux de Paris (AP-HP), Université Paris Est Créteil, Créteil, France.; INSERM U955, Université Paris Est Créteil (UPEC), Créteil, France., Perima A; Institut Pasteur, Université Paris Cité, INSERM UMR1222, Unit of Antibodies in Therapy and Pathology, Paris, France., Iannascoli B; Institut Pasteur, Université Paris Cité, INSERM UMR1222, Unit of Antibodies in Therapy and Pathology, Paris, France., Richard-Le Goff O; Institut Pasteur, Université Paris Cité, INSERM UMR1222, Unit of Antibodies in Therapy and Pathology, Paris, France., Castrillon C; Institut Pasteur, Université Paris Cité, INSERM UMR1222, Unit of Antibodies in Therapy and Pathology, Paris, France., Mottet G; Institut Pasteur, Université Paris Cité, INSERM UMR1222, Unit of Antibodies in Therapy and Pathology, Paris, France., Sterlin D; Institut Pasteur, Université Paris Cité, INSERM UMR1222, Unit of Antibodies in Therapy and Pathology, Paris, France., Robbins A; Department of Internal Medicine, Infectious Diseases, and Clinical Immunology, Robert Debré Hospital, Reims University Hospitals, Reims, France., Michel M; Centre Hospitalier Universitaire Henri-Mondor, Université Paris Est Créteil, Créteil, France.; Paris Est Créteil University UPEC, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Créteil, France., England P; Plateforme de Biophysique Moléculaire, Institut Pasteur, CNRS UMR3528, Paris, France., Millot GA; Hub Bioinformatique et Biostatistique - DBC, Institut Pasteur, Paris, France., Eyer K; Laboratory for Functional Immune Repertoire Analysis, Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland., Baudry J; Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France., Mahevas M; Institut Necker-Enfants Malades, INSERM U1151/CNRS UMS8253, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.; Service de Médecine Interne, Centre national de référence des cytopénies auto-immunes de l'adulte, Hôpital Henri Mondor, Assistance Publique Hôpitaux de Paris (AP-HP), Université Paris Est Créteil, Créteil, France.; Paris Est Créteil University UPEC, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Créteil, France., Bruhns P; Institut Pasteur, Université Paris Cité, INSERM UMR1222, Unit of Antibodies in Therapy and Pathology, Paris, France.; Paris Est Créteil University UPEC, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Créteil, France.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2022 Jun 15; Vol. 132 (12).

Zobrazit plný text záznamu

Akademický článek

An Engineered Human Fc variant With Exquisite Selectivity for FcγRIIIa V158 Reveals That Ligation of FcγRIIIa Mediates Potent Antibody Dependent Cellular Phagocytosis With GM-CSF-Differentiated Macrophages.

Autor: Kang TH; Department of Chemical Engineering, University of Texas at Austin, Austin, TX, United States., Lee CH; Department of Chemical Engineering, University of Texas at Austin, Austin, TX, United States., Delidakis G; Department of Chemical Engineering, University of Texas at Austin, Austin, TX, United States., Jung J; Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, United States., Richard-Le Goff O; Unit of Antibodies in Therapy and Pathology, Department of Immunology, Institut Pasteur, Paris, France., Lee J; Department of Chemical Engineering, University of Texas at Austin, Austin, TX, United States., Kim JE; Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, United States., Charab W; Department of Chemical Engineering, University of Texas at Austin, Austin, TX, United States., Bruhns P; Unit of Antibodies in Therapy and Pathology, Department of Immunology, Institut Pasteur, Paris, France.; INSERM, U1222, Paris, France., Georgiou G; Department of Chemical Engineering, University of Texas at Austin, Austin, TX, United States.; Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, United States.; Center for Systems and Synthetic Biology, University of Texas at Austin, Austin, TX, United States.; Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2019 Mar 27; Vol. 10, pp. 562. Date of Electronic Publication: 2019 Mar 27 (Print Publication: 2019).

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání